• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Google Ventures

three spotlights on a stage
Biotech

It's curtain close for Spotlight: Gene editing biotech shutters

Spotlight had launched in 2020 with money from Alphabet’s venture capital arm GV (Google Ventures).
Gabrielle Masson Feb 19, 2025 4:28pm
Ros Deegan CEO OMass Therapeutics

GV, Sanofi drive preclinical British biotech to $100M series B

Apr 28, 2022 2:00am
DNA strand genome

DNAnexus snags $200M to grow genomic data analytics tech

Mar 8, 2022 1:00pm
A sheet of paper reading venture capital

Seismic, padded by ex-Pandion C-suite, unveils with $101M

Feb 9, 2022 7:00am
Leyden Labs CEO Koenraad Wiedhaup

Leyden nabs $140M to stop viruses 'at the gate' with nasal spray

Jan 25, 2022 7:00am
Money piles cash

Verana Health lands J&J, Novo backing in $150M round

Jan 14, 2022 10:35am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings